The US Centers for Disease Control and Prevention (CDC) today updated its Zika antibody testing guidance for women who live in or travel to affected areas, based on the latest evidence that Zika virus immunoglobulin M (IgM) antibodies can persist beyond 12 weeks in some infected patients.